Mereo BioPharma (MREO) Cash from Investing Activities (2023 - 2025)
Mereo BioPharma (MREO) has disclosed Cash from Investing Activities for 3 consecutive years, with $300000.0 as the latest value for Q3 2025.
- Quarterly Cash from Investing Activities changed N/A to $300000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$20000.0 through Dec 2025, up 97.14% year-over-year, with the annual reading at -$20000.0 for FY2025, 97.14% up from the prior year.
- Cash from Investing Activities for Q3 2025 was $300000.0 at Mereo BioPharma, up from -$320000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $300000.0 in Q3 2025, with the low at -$700000.0 in Q1 2024.
- Average Cash from Investing Activities over 3 years is -$227600.0, with a median of -$320000.0 recorded in 2025.
- The sharpest move saw Cash from Investing Activities crashed 67.06% in 2024, then soared 54.29% in 2025.
- Over 3 years, Cash from Investing Activities stood at -$419000.0 in 2023, then skyrocketed by 100.24% to $1000.0 in 2024, then skyrocketed by 29900.0% to $300000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at $300000.0, -$320000.0, and $1000.0 for Q3 2025, Q1 2025, and Q2 2024 respectively.